The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Evidence that the plant cannabinoid Δ9‐tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist
Open accessAbstract
Δ 9‐tetrahydrocannabivarin (THCV) displaced [3 H]CP55940 from specific binding sites on mouse brain and CHO‐hCB 2 cell membranes (Ki=75.4 and 62.8 n M, respectively). THCV (1 μM) also antagonized CP55940‐induced stimulation of [35 S]GTP γ S binding to these membranes (apparent KB=93.1 and 10.1 n M, respectively). In the mouse vas deferens, the ability of Δ 9‐tetrahydrocannabinol (THC) to inhibit electrically evoked contractions was antagonized by THCV, its apparent KB‐value (96.7 n M) approximating the apparent KB‐values for its antagonism of CP55940‐ and R‐(+)‐WIN55212‐induced stimulation of [35 S]GTP γ S binding to mouse brain membranes. THCV also antagonized R‐(+)‐WIN55212, anandamide, methanandamide and CP55940 in the vas deferens, but with lower apparent KB‐values (1.5, 1.2, 4.6 and 10.3 n M, respectively). THCV (100 n M) did not oppose clonidine, capsaicin or (−)‐7‐hydroxy‐cannabidiol‐dimethylheptyl‐induced inhibition of electrically evoked contractions of the vas deferens. Contractile responses of the vas deferens to phenylephrine hydrochloride or β,γ‐methylene‐ATP were not reduced by 1 μM THCV or R‐(+)‐WIN55212, suggesting that THCV interacts with R‐(+)‐WIN55212 at prejunctional sites. At 32 μM, THCV did reduce contractile responses to phenylephrine hydrochloride and β,γ‐methylene‐ATP, and above 3 μM it inhibited electrically evoked contractions of the vas deferens in an SR141716A‐independent manner. In conclusion, THCV behaves as a competitive CB 1 and CB 2 receptor antagonist. In the vas deferens, it antagonized several cannabinoids more potently than THC and was also more potent against CP55940 and R‐(+)‐WIN55212 in this tissue than in brain membranes. The bases of these agonist‐ and tissue‐dependent effects remain to be established. British Journal of Pharmacology(2005)146, 917–926. doi:10.1038/sj.bjp.0706414
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Ross, R. A., Gibson, T. M., Brockie, H. C., Leslie, M., Pashmi, G., Craib, S. J., Di Marzo, V., & Pertwee, R. G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703850 · Cited by 237 · cited 2×
“Thus, some of these proposed targets are activated by capsaicin (Ross et al., 2001; Hájos & Freund, % In hi bi tio n ± s. e. m ea n British Journal of Pharmacology vol 146 (7) 2002) or clonidine (Molderings et al., 2002), while others appear not to be activated by CP55940 (Breivogel et al.,…”
Background
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 621
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Metadata
- Authors
- Thomas, A., Stevenson, L. A., Wease, K. N., Price, M. R., Baillie, G., Ross, R. A., & Pertwee, R. G.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-12
- Volume
- 146
- Issue
- 7
- Pages
- 917-926
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1974564599
- Cited by
- 179
- References
- 2
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence that the plant cannabinoid Δ9‐tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist. https://app.cochat.ai/papers/10.1038/sj.bjp.0706414
- The paper
- Thomas, A., Stevenson, L. A., Wease, K. N., Price, M. R., Baillie, G., Ross, R. A., & Pertwee, R. G. (2005). Evidence that the plant cannabinoid Δ9‐tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.